A double-blind, placebo-controlled, randomized phase III trial of gemcitabine (G) plus bevacizumab (B) versus gemcitabine plus placebo (P) in patients (pts) with advanced pancreatic cancer (PC): A preliminary analysis of Cancer and Leukemia Group B (CALGB) Meeting Abstract


Authors: Kindler, H. L.; Niedzwiecki, D.; Hollis, D.; Oraefo, E.; Schrag, D.; Hurwitz, H.; McLeod, H. L.; Mulcahy, M. F.; Schilsky, R. L.; Goldberg, R. M.; Cancer and Leukemia Group B
Abstract Title: A double-blind, placebo-controlled, randomized phase III trial of gemcitabine (G) plus bevacizumab (B) versus gemcitabine plus placebo (P) in patients (pts) with advanced pancreatic cancer (PC): A preliminary analysis of Cancer and Leukemia Group B (CALGB)
Meeting Title: 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 25
Issue: 18 Suppl.
Meeting Dates: 2007 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2007-06-20
Start Page: 199s
Language: English
ACCESSION: WOS:000455043700798
PROVIDER: wos
DOI: 10.1200/jco.2007.25.18_suppl.4508
Notes: Meeting Abstract: 4508 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Deborah Schrag
    236 Schrag